April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Association of Dyslipidemia in Moderate to Severe Meibomian Gland Dysfunction: A Retrospective Study
Author Affiliations & Notes
  • A. H. Dao
    Department of Ophthalmology and Visual Science, University of Texas Medical School at Houston, Houston, Texas
  • J. D. Spindle
    Department of Ophthalmology and Visual Science, University of Texas Medical School at Houston, Houston, Texas
  • B. A. Harp
    Department of Ophthalmology and Visual Science, University of Texas Medical School at Houston, Houston, Texas
  • A. T. Jacob
    Department of Ophthalmology and Visual Science, University of Texas Medical School at Houston, Houston, Texas
  • A. Z. Chuang
    Department of Ophthalmology and Visual Science, University of Texas Medical School at Houston, Houston, Texas
  • R. W. Yee
    Department of Ophthalmology and Visual Science, University of Texas Medical School at Houston, Houston, Texas
  • Footnotes
    Commercial Relationships  A.H. Dao, None; J.D. Spindle, None; B.A. Harp, None; A.T. Jacob, None; A.Z. Chuang, None; R.W. Yee, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 6249. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. H. Dao, J. D. Spindle, B. A. Harp, A. T. Jacob, A. Z. Chuang, R. W. Yee; Association of Dyslipidemia in Moderate to Severe Meibomian Gland Dysfunction: A Retrospective Study. Invest. Ophthalmol. Vis. Sci. 2010;51(13):6249.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To examine whether or not there is an association between dyslipidemia and moderate to severe meibomian gland dysfunction, a disease that is a major contributor to dry eye disease.

Methods: : This is a retrospective study involving 66 patients in our clinic from January 2008 to July 2009 with moderate to severe meibomian gland dysfunction whose serum lipid levels were obtained. Of these, 2 patients were excluded due to rheumatologic disease and 15 patients were excluded from the analysis due to their taking either an omega-3 fatty acid supplement (n=6) or a statin (n=9). Of the 46 remaining patients, 22 were male and 24 were female, the average age was 52.0 years, and the range in age was 27-82. The prevalence of dyslipidemia as defined as total cholesterol >200 mg/dL, low-density lipoprotein (LDL) >130 mg/dL, high-density lipoprotein (HDL), and triglycerides (>150 mg/dL) was compared in these patients to the general population as reported by data from the National Health and Nutrition Examination Survey (NHANES).

Results: : Patients with moderate to severe MGD had a higher incidence of dyslipidemia with respect to elevated total cholesterol (>200 mg/dL), 67.4% to 45.1% (p=0.0012) when compared to population controls. There was a smaller number of MGD patients with low HDL, 15.2% when compared to controls, 33.1% (p-value=0.0049).The incidence of increased LDL was not statistically significant (p-value=0.184). There was a statistically smaller number of MGD patients with high triglycerides (TG >150 mg/dL), 15.2% when compared to controls, 33.1% (p-value=0.0049).

Conclusions: : Patients with moderate to severe MGD have a higher incidence of dyslipidemia with respect to elevated total cholesterol than the general population. The component of total cholesterol that contributed most to this increase in total cholesterol came from elevated serum HDL levels. To our knowledge, elevated HDL has not been associated with any pathological state. Patients with MGD had a statistically significant lower incidence of hypoalphalipoproteinemia (low HDL) than the general population. The potential to screen for dyslipidemia on physical exam at the slit lamp is an exciting finding.

Keywords: cornea: tears/tear film/dry eye • clinical (human) or epidemiologic studies: risk factor assessment • lipids 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×